PUBLICATIONS · 17505072
Oral sodium clodronate for nonmetastatic prostate cancer--results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Natl Cancer Inst
- Publication date
- 2007 May 16
- First author
- Mason MD
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Natl Cancer Inst. 2007 May 16;99(10):744-5. doi: 10.1093/jnci/djk194.
- note
- Source null
- related pmid
- 17505065
- relationship
- Comment in
- citation
- Nat Clin Pract Urol. 2007 Nov;4(11):584-5. doi: 10.1038/ncpuro0911.
- note
- Source null
- related pmid
- 17726430
- relationship
- Comment in
Authors and identifiers
- name
- Mason MD
- type
- Author
- name
- Sydes MR
- type
- Author
- name
- Glaholm J
- type
- Author
- name
- Langley RE
- type
- Author
- name
- Huddart RA
- type
- Author
- name
- Sokal M
- type
- Author
- name
- Stott M
- type
- Author
- name
- Robinson AC
- type
- Author
- name
- James ND
- type
- Author
- name
- Parmar MK
- type
- Author
- name
- Dearnaley DP
- type
- Author
- name
- Medical Research Council PR04 Collaborators
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Mason MD
- type
- Author
- name
- Sydes MR
- type
- Author
- name
- Glaholm J
- type
- Author
- name
- Langley RE
- type
- Author
- name
- Huddart RA
- type
- Author
- name
- Sokal M
- type
- Author
- name
- Stott M
- type
- Author
- name
- Robinson AC
- type
- Author
- name
- James ND
- type
- Author
- name
- Parmar MK
- type
- Author
- name
- Dearnaley DP
- type
- Author
- name
- Medical Research Council PR04 Collaborators
- type
- CollectiveName
- bibliography ids
- nci-bib-4cd8c94c19f4851492db85a5
- book metadata
- content sha256
- acab353a2f0f0d62eeca10730735bddd39e0c4ad0e443f426f8d17055c72a32d
- document type
- citation
- dois
- 10.1093/jnci/djk178
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:17505072
- immutable id
- pubmed:17505072@acab353a2f0f0d62eeca10730735bddd39e0c4ad0e443f426f8d17055c72a32d
- journal
- abbreviation
- J Natl Cancer Inst
- issn electronic
- 1460-2105
- issn print
- 0027-8874
- issue
- 10
- name
- Journal of the National Cancer Institute
- nlm unique id
- 7503089
- pages
- 765-76
- volume
- 99
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Natl Cancer Inst. 2007 May 16;99(10):744-5. doi: 10.1093/jnci/djk194.
- note
- Source null
- related pmid
- 17505065
- relationship
- Comment in
- citation
- Nat Clin Pract Urol. 2007 Nov;4(11):584-5. doi: 10.1038/ncpuro0911.
- note
- Source null
- related pmid
- 17726430
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 17505072
- provenance
- batch id
- de363a11f4b1613edab0
- provider
- NCBI PubMed ESummary
- record sha256
- d974534e8f6280eacc2b82f236d57512be90e06129e9244b204f64c5eb92905f
- response sha256
- a83f066085229c55d3d0ec880c129c835ac872440e73f5fc2b7131ecfb2a254f
- retrieved at
- 2026-09-09T23:46:14.107379+00:00
- publication date
- display
- 2007 May 16
- precision
- day
- year
- 2007
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Oral sodium clodronate for nonmetastatic prostate cancer--results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873).
Preserved source evidence · Not medical advice
Triangle